Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baltic Post-marketing Program of PEGASYS (Peginterferon alfa-2a 40KD) in HBeAg-positive Chronic Hepatitis B
2006-005370-49Phase 4Completed
- Sponsor
- Roche
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of peginterferon alfa-2a in Chronic Hepatitis B (CHB) and Chronic hepatitis B (CHB), sponsored by Roche. Primary endpoint: HBV DNA <100,000 cpm. Started Nov 2006; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
Chronic Hepatitis B (CHB)Chronic hepatitis B (CHB)
Beyond the preview
Go deeper on 2006-005370-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005370-49.